Literature DB >> 7569954

Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.

R Y Poon1, T Hunter.   

Abstract

The activation of cyclin-dependent kinases (CDKs) requires the phosphorylation of a conserved threonine (Thr160 in Cdk2) by CDK-activating kinase (CAK). Human KAP (also called Cdi1), a CDK-associated phosphatase, was shown to dephosphorylate Thr160 in human Cdk2. KAP was unable to dephosphorylate Tyr15 and only dephosphorylated Thr160 in native monomeric Cdk2. The binding of cyclin A to Cdk2 inhibited the dephosphorylation of Thr160 by KAP but did not preclude the binding of KAP to the cyclin A-Cdk2 complex. Moreover, the dephosphorylation of Thr160 by KAP prevented Cdk2 kinase activity upon subsequent association with cyclin A. These results suggest that KAP binds to Cdk2 and dephosphorylates Thr160 when the associated cyclin subunit is degraded or dissociates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569954     DOI: 10.1126/science.270.5233.90

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  46 in total

Review 1.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

2.  Cdc14 phosphatases preferentially dephosphorylate a subset of cyclin-dependent kinase (Cdk) sites containing phosphoserine.

Authors:  Steven C Bremmer; Hana Hall; Juan S Martinez; Christie L Eissler; Thomas H Hinrichsen; Sandra Rossie; Laurie L Parker; Mark C Hall; Harry Charbonneau
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

Review 3.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

4.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.

Authors:  Stéphane Larochelle; Karl A Merrick; Marie-Emilie Terret; Lara Wohlbold; Nora M Barboza; Chao Zhang; Kevan M Shokat; Prasad V Jallepalli; Robert P Fisher
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

5.  PTEN: sometimes taking it off can be better than putting it on.

Authors:  M P Myers; N K Tonks
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

6.  Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.

Authors:  D Tedesco; L Baron; L Fischer-Fantuzzi; C Vesco
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 7.  Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer.

Authors:  W Douglas Cress; Peng Yu; Jie Wu
Journal:  Int J Biochem Cell Biol       Date:  2017-05-11       Impact factor: 5.085

8.  DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase.

Authors:  Jeremy P H Chow; Wai Yi Siu; Tsz Kan Fung; Wan Mui Chan; Anita Lau; Talha Arooz; Chuen-Pei Ng; Katsumi Yamashita; Randy Y C Poon
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

9.  Machine learning methods for prediction of CDK-inhibitors.

Authors:  Jayashree Ramana; Dinesh Gupta
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

10.  Protein phosphatase 2A promotes the transition to G0 during terminal differentiation in Drosophila.

Authors:  Dan Sun; Laura Buttitta
Journal:  Development       Date:  2015-08-07       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.